Clinical Trial

Navigating the Clinical Research Process for Lymphoma

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 6, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Participation in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of lymphoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future lymphoma patients.
Trial Details
NCT Number NCT06070246
Lead Sponsor Power Life Sciences Inc.
Conditions Lymphoma
Enrollment 500 participants
Start Date 2024-10
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2023-10-06